Login / Signup

Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.

Francesca Romana SpinelliFulvia CeccarelliManuela Di FrancoFabrizio Conti
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • sars cov
  • randomized controlled trial
  • respiratory syndrome coronavirus
  • coronavirus disease